|
 |
Thomas B. Julian, M.D.
Principal hospital base:
Allegheny General Hospital
Current professional and academic appointments (Include starting date):
| 1997 - present: |
|
Associate Professor of Human Oncology, Drexel University College of Medicine (formerly MCP Hahnemann) |
| 1997 - present: |
|
Associate Director Medical Oversight, NSABP |
| 1998 - present: |
|
Acting Associate Director, Allegheny Breast Center, Allegheny General Hospital |
| 1994 - present: |
|
Staff Surgeon, Division of Surgical Oncology, Allegheny General Hospital |
Undergraduate medical education (including dates and degrees):
| 1972 - 1976: |
|
M.D., University of Pittsburgh School of Medicine, Pittsburgh, PA |
Postgraduate medical education (including dates of internships, residencies, fellowships, etc.):
| 1976 - 1977: |
|
General Surgery Internship, University of Pittsburgh Health Center Hospitals, Pittsburgh, PA |
| 1977 - 1981: |
|
General Surgery Residency, University of Pittsburgh Health Center Hospitals, Pittsburgh, PA |
| 1981 - 1982: |
|
General Surgery Senior Resident, University of Pittsburgh Health Center Hospitals, Pittsburgh, PA |
Research Activities:
| Therapeutic interventions: |
|
Sentinel Lymphatic Mapping for Breast Cancer. |
| Funding source: |
|
Ethicon Grant. |
|
| Therapeutic interventions: |
|
A Pilot Clinical Trial to Assess (Mammotomy) in Women with Malignant Tumors. |
| Funding source: |
|
Department of Defense - U.S. Army Breast Cancer Grant. |
|
| Therapeutic interventions: |
|
Minimally Invasive Cryosurgery in the Breast. |
| Funding source: |
|
Biopsys / Ethicon Grant. |
|
| Therapeutic interventions: |
|
High-Risk Breast cancer Screening Pilot Clinical Trial. |
| Funding source: |
|
Biopsys / Ethicon Grant. |
|
| Therapeutic interventions: |
|
Evaluation of the Ability of the 8 Gauge Hand Held Mammotome and the 11 Gauge Hand Held Mammotome Breast Biopsy System to completely Remove a Low-Risk Palpable Mass Under Ultrasound Guidance. |
| Funding source: |
|
Biopsys / Ethicon Grant. |
Recent publications and presentations:
Peer-reviewed publications (i.e., journal articles)
Kuerer HM, Julian TB, Strom EA, Lyerly HK, Guiliano EG, Mamounas EP, Vincini FA. Accelerated partial breast irradiation after conservative surgery for breast cancer. Annals of Surgery, In Press.
Julian TB, Land SR, Wolmark N: NSABP B-35: A clinical trial comparing anastrozole with tamoxifen in post menopausal patients with ductal carcinoma in situ (DCIS) undergoing lumpectomy with radiation theray, Breast Diseases, 2003;14:121-122..
Patel NA, Dusi D, Bragdon G, Julian TB, Technical limitations of sentinel node biopsy in breast cancer: a single surgeon's experience. Am Surg. 2003 Feb;69(2):111-6.
Krag D, Julian TB. Update on NSABP B-32 a randomized phase III clinical trial to compare sentinel node resection to conventional axillary dissection for clinically node-negative breast cancer. Breast Diseases 2002;13:113-114.
Julian TB, Dusi D, Wolmark N. Sentinel node biopsy after neoadjuvant chemotherapy for breast cancer. Am J Surg. 2002 Oct;184(4):315-7.
Saad RS, Silverman JF, Julian T, Clary KM, Sturgis CD. Atypical squamous metaplasia of seromas in breast needle aspirates from irradiated lumpectomy sites: a potential pitfall for false-positive diagnoses of carcinoma. Diagn Cytopathol. 2002 Feb;26(2):104-8.
Julian TB, Patel N, Dusi D, Olson P, Nathan G, Jasnosz K, Isaacs G, Wolmark N. Sentinel lymph node biopsy after neoadjuvant chemotherapy for breast cancer. Am J Surg. 2001 Oct;182(4):407-10.
Janocko LE, Brown KA, Smith CA, Gu LP, Pollice AA, Singh SG, Julian T, Wolmark N, Sweeney L, Silverman JF, Shackney SE. Distinctive patterns of Her-2/neu, c-myc, and cyclin D1 gene amplification by fluorescence in situ hybridization in primary human breast cancers. Cytometry. 2001 Jun 15;46(3):136-49.
Smith CA, Pollice AA, Gu LP, Brown KA, Singh SG, Janocko LE, Johnson R, Julian T, Hyams D, Wolmark N, Sweeney L, Silverman JF, Shackney SE. Correlations among p53, Her-2/neu, and ras overexpression and aneuploidy by multiparameter flow cytometry in human breast cancer: evidence for a common phenotypic evolutionary pattern in infiltrating ductal carcinomas. Clin Cancer Res. 2000 Jan;6(1):112-26.
Rabin Y, Julian TB, Olson P, Taylor MJ, Wolmark N. Long-term follow-up post-cryosurgery in a sheep breast model. Cryobiology. 1999 Aug;39(1):29-46.
Other publications (i.e., non-peer-reviewed articles, book chapters, etc.)
Rabin Y, Julian TB, Olson P. Minimally Invasive Breast Cryosurgery, in, Basics of Cryosurgery, (Korpan, NlK., Ed.), Springer-Verlag, Vienna, Austria, pp. 213-223, 2001.
Julian TB. MRI: a role in clinical trials. J Magn Reson Imaging. 2001 Jun;13(6):837-41. Review.
Julian T, Patel N, Dusi D, Olson P, Nathan G, Jasnosz K, Isaacs G, Wolmark N; Sentinel Node Biopsy After Neoadjuvant Chemotherapy for Breast Cancer, The American Socity of Surgeons, La Jolla, CA, May, 2001. Published Abstract.
Julian TB. Laparoscopic Liver Surgery, Prevention & Management of Laparoendoscopic Surgical Complications, 1999.
National/regional presentations
International Oncology Conference, Pittsburgh, PA. Surgical Treatment of Breast Cancer: The role of Sentinel Node Lymphatic Mapping. May 17, 2001.
The American Society of Breast Surgeons, LaJolla, CA. Sentinel Lymph Node Biopsy (SNB) after Neoadjuvant Chemotherapy for Breast Cancer. May 5, 2001.
53rd Annual Midwest Cancer Conference, Wichita, KS. Sentinel Node Evaluation. March 9, 2001.
Other presentations
21st Annual Pittsburgh Breast Imaging Seminar, Pittsburgh, PA, Presentation topics: Surgery: Sentinel Node Retrieval, Segmental Resection, Sentinel Node: Where are we Today. August 8 - 10, 2003.Pittsburgh, PA.
Armstrong County Memorial Hospital, Advances in the Treatment of Neo-Adjuvant Breast Cancer, July 21, 2003. Ford City, PA.
German Senologie Congress, Accuracy of Sentinel Node Biopsy Following Neoadjuvant Chemotherapy in Breast Cancer, June 19, 2003. Munich, Germany.
American Brachytherapy Society, Phase III Protocol Development, May 2, 2003, New York, NY.
American Society of Breast Surgeons, NSABP: An Update on Present and Future Clinical Trials, May 3, 2003, Atlanta, GA.
LITE Symposium, Breast Cancer Management, February 28, 2003, Pittsburgh, PA.
Butler County Medical Society, Neoadjuvant Chemotherapy in Breast Cancer, February 18, 2002, Butler, PA.
Highlights of the 2002 San Antonio Breast Cancer Symposium, Surgical Update for Breast Cancer, January 17, 2003, Allegheny General Hospital, Pittsburgh, PA.
8th annual Puerto Breast Cancer Conference. Sentinel Node Lymphatic Mapping and NSABP-B32. October 11 - 13, 2002, Isla Verde, Puerto Rico.
NOCR - Challenging Cases in Oncology. Locally Advanced Disease: Neo-adjuvant Therapy, September 14, 2002. Washington, DC.
> Back to Combined Faculty Listing
|